3 news items
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
and atezolizumab. The main goals are to measure how well the treatments work and their safety. Additionally, the study will look at progression-free survival (how
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
. The main goals are to measure how well the treatments work and their safety. Additionally, the study will look at progression-free survival (how long
Candel Therapeutics Receives FDA Orphan Drug Designation For CAN-2409 For The Treatment Of Pancreatic Cancer
CADL
11 Apr 24
, are urgently needed.Surgical resection offers the only chance of cure; thus, a major therapeutic goal for patients with non-metastatic disease
- Prev
- 1
- Next